Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02003 (
NBT
)
1,323
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The homophilic cell adhesion molecule
CEACAM1
(C-CAM, BGP, CD66a) occurs as two coexpressed isoforms,
CEACAM1
-L and
CEACAM1
-S, in epithelia, endothelia, and leukocytes.
CEACAM1
-L can inhibit tumor growth; this effect is influenced by
CEACAM1
-S. To characterize the growth regulatory properties of
CEACAM1
, we analyzed the expression patterns of the isoforms, and here we demonstrate that both the expression levels and the S:L isoform ratios differ in proliferating and quiescent rat epithelial cells. Quiescent prostate NbE cells expressed more
CEACAM1
than quiescent bladder
NBT
-II cells, a pattern that correlated with the expression levels in the parental tissues. In contrast, both the expression levels and the isoform ratios were strikingly similar in proliferating NbE and
NBT
-II cells, showing that a particular
CEACAM1
expression pattern is compatible with cell proliferation. However, in confluent cells,
CEACAM1
seemed to exert inhibitory effects on cell proliferation. Addition of anti-
CEACAM1
antibodies to quiescent, confluent cells caused decreased expression of the cyclin-dependent kinase inhibitor, p27Klp1, stimulated growth factor-dependent DNA synthesis, and altered the S:L isoform ratio toward the ratio characteristic of proliferating cells. Taken together, our data suggest that
CEACAM1
contributes to contact inhibition of cell proliferation in confluent cells but allows proliferation when expressed at different isoform ratios.
...
PMID:The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. 1072 82
Growth factor receptors, extracellular matrix receptors, and cell-cell adhesion molecules co-operate in regulating the activities of intracellular signaling pathways. Here, we demonstrate that the cell adhesion molecule
CEACAM1
co-regulates growth-factor-induced DNA synthesis in
NBT
-II epithelial cells in a cell-density-dependent manner.
CEACAM1
exerted its effects by regulating the activity of the Erk 1/2 MAP kinase pathway and the expression levels of the cyclin-dependent kinase inhibitor p27(Kip1). Interestingly, both inhibitory and stimulatory effects were observed. Confluent cells continuously exposed to fetal calf serum showed little Erk activity and DNA synthesis compared with sparse cells. Under these conditions, anti-
CEACAM1
antibodies strongly stimulated Erk activation, decreased p27 expression, and induced DNA synthesis. In serum-starved confluent cells, re-addition of 10% fetal calf serum activated the Erk pathway, decreased p27 expression, and stimulated DNA synthesis to the same levels as in sparse cells. Under these conditions anti-
CEACAM1
antibodies de-activated Erk, restored the level of p27, and inhibited DNA synthesis. These data indicate that
CEACAM1
mediates contact inhibition of proliferation in cells that are constantly exposed to growth factors, but co-activates growth-factor-induced proliferation in cells that have been starved for growth factors; exposure to extracellular
CEACAM1
ligands reverts these responses.
...
PMID:Control of density-dependent, cell state-specific signal transduction by the cell adhesion molecule CEACAM1, and its influence on cell cycle regulation. 1595 Jun 23
The homophilic cell-cell adhesion receptor
CEACAM1
(carcinoembryonic antigen-related cell adhesion molecule 1, CD66a) acts as a regulator of contact-dependent cell survival, differentiation, and growth. It is involved in the control of proliferation in hematopoietic and epithelial cells and can act as a tumor suppressor. In this study, we identify DNA polymerase delta-interacting protein 38 (PDIP38) as a novel binding partner for
CEACAM1
-L and
CEACAM1
-S. We show that PDIP38 can occur in the nucleus, in the cytoplasm and at the plasma membrane in
NBT
-II, IEC18, RBE, and HeLa cells and that the distribution in
NBT
-II cells is influenced by the confluency of the cells. We also demonstrate that the interaction of
CEACAM1
and PDIP38 is of functional importance in
NBT
-II cells, which co-express the long and the short
CEACAM1
isoform. In subconfluent, proliferating
NBT
-II cells, perturbation of
CEACAM1
by antibody clustering induces increased binding to PDIP38 and results in rapid recruitment of PDIP38 to the plasma membrane. The same treatment of confluent, quiescent
NBT
-II cells leads to a different response, i.e. translocation of PDIP38 to the nucleus. Together, our data show that PDIP38 can shuttle between the cytoplasmic and the nuclear compartments and that its subcellular localization is regulated by
CEACAM1
, implicating that PDIP38 may constitute a novel downstream target of
CEACAM1
signaling.
...
PMID:The cell adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1 regulates nucleocytoplasmic trafficking of DNA polymerase delta-interacting protein 38. 1762 71